Quick Answer
EU innovation procurement covers three mechanisms: PCP (Pre-Commercial Procurement — buy R&D services to develop solutions), PPI (Public Procurement of Innovative Solutions — be the first commercial buyer), and Innovation Partnerships (develop and buy in a single procedure). All three are accessible to SMEs and startups, offer IP retention for suppliers, and are funded through Horizon Europe, national RRF plans, and sector programmes. Active in: health, climate, digital, defense, transport, and agri-food.
Pre-Commercial Procurement (PCP): Funding Innovation Development
PCP is a competitive R&D procurement mechanism where public authorities purchase the development of new solutions across phased contracts. It operates outside standard procurement directives under the R&D services exemption (Article 14 of Directive 2014/24/EU).
How PCP Phases Work
| Phase | Activity | Typical Contract Value | Suppliers Selected |
|---|---|---|---|
| Phase 1 | Feasibility study and concept design | €50K–€150K | 5–10 suppliers |
| Phase 2 | Prototype development | €200K–€500K | 2–4 suppliers |
| Phase 3 | Pilot testing and evaluation | €500K–€2M | 1–3 suppliers |
After Phase 3, the authority evaluates whether the solution has reached sufficient maturity for commercial procurement (PPI). Suppliers are not guaranteed a follow-on commercial contract — but they retain IP rights to what they've developed, which is commercially valuable regardless.
IP Rights in PCP: Why Suppliers Benefit
Unlike standard government R&D contracts where the authority often claims ownership of results, PCP follows an IP sharing model:
- Suppliers retain ownership of background IP (existing knowledge brought in)
- Suppliers retain ownership of foreground IP (results generated during PCP)
- The procuring authority gets a licence to use the results for its own purposes
- If the authority doesn't exploit the IP within a reasonable period, suppliers can commercialise freely
This IP structure makes PCP accessible to innovative SMEs and startups that would otherwise reject contracts where the government claims ownership of their technology.
Public Procurement of Innovative Solutions (PPI): First Commercial Purchase
PPI is a demand aggregation mechanism where public authorities act as early adopters of solutions that exist but haven't yet been scaled commercially. Rather than buying the cheapest available solution, the authority actively chooses the innovative option to create market pull.
PPI differs from normal procurement in intent: The authority is explicitly choosing to pay a premium for novelty and innovation, with the objective of stimulating the EU market for that technology. PPI notices explicitly state the "functional requirements" rather than specifying known solutions — this opens competition to suppliers with innovative approaches that meet the functional need.
Active PPI Areas in 2026
- Healthcare: AI-assisted diagnosis tools, remote patient monitoring platforms, personalised medicine data systems
- Climate: Low-carbon construction materials, hydrogen fuel cell municipal vehicles, carbon capture integration
- Digital government: AI-powered citizen services, automated permit processing, fraud detection systems
- Defense: Dual-use surveillance technology, drone detection systems, autonomous logistics
- Agri-food: Precision agriculture platforms, food safety traceability systems, lab-grown protein alternatives
Innovation Partnership: Develop and Buy in One Procedure
The Innovation Partnership procedure (Article 31 Directive 2014/24/EU) allows a contracting authority to select partners to develop a novel solution AND commit to purchasing it upon successful development — all in a single procurement. This removes the gap between PCP (funded R&D) and PPI (commercial purchase) by combining both phases.
Key features:
- Competitive dialogue to design and select development partners
- Structured development milestones with go/no-go decision points
- Purchase commitment upon satisfactory development completion
- IP negotiation included in the partnership agreement
- Can involve multiple development partners in parallel (best solution wins the purchase contract)
Key EU PCP/PPI Programmes in 2026
| Programme | Focus Area | Budget |
|---|---|---|
| LEIT-ICT Horizon Europe | AI, cloud, cybersecurity PCP | €13.5B (WP) |
| EDCTP / HERA | Medical countermeasures R&D | €2.4B |
| EDF (European Defence Fund) | Defense technology R&D procurement | €8B (2021–27) |
| National RRF Digital Components | GovTech, smart city, e-health | Varies by MS |
How to Find and Win PCP/PPI Opportunities
Monitor CPV 73000000–73430000: R&D and research service contracts on TED include PCP phase notices. Set TED eSentinel or TenderMetric alerts for this CPV range filtered to your sector.
Watch Prior Information Notices (PINs): PCP programmes typically publish a PIN 3–6 months before the formal call to attract potential participants. This window is critical for market engagement meetings — understanding requirements before competitors do.
Engage with the Horizon Europe NCP network: National Contact Points (NCPs) provide free coaching on PCP/PPI participation in your country. They have advance information on upcoming calls and can facilitate introductions with procuring authorities.
Build a consortium: PCP Phase 2–3 contracts often require multidisciplinary teams. A pre-formed consortium of technology developer + user organisation + validation partner is a strong proposal structure.
Find Innovation Procurement Tenders
Monitor live EU R&D, innovation, and technology tenders across all sectors and member states.